Polisan has initiated an international clinical trial to evaluate Citoflavin (inosine/nicotinamide/riboflavin/succinic acid) for the treatment of diabetic polyneuropathy, a common complication of diabetes. According to the company’s press service, the …
Today’s Diabetes News, your ultimate destination for up-to-date and insightful information on diabetes, health tips, and living a fulfilling life with diabetes. Our mission is to empower and support individuals with diabetes, their loved ones, and the wider community by providing reliable, relevant, and engaging content that fosters a healthier and happier life.
Copyright MatchingDonors.com©️ 2025 All rights reserved.
